Macromolecular effects of AU1235 on whole M. tb cells -The effects of AU1235 on the biosynthesis of DNA, RNA, proteins and cell envelope components (fatty acids, mycolic acids, (glyco)lipids and polysaccharides) of whole M. tb H37Ra cells were assessed by metabolic labeling. To this end, bacterial cultures were grown in 7H9-OADC-Tween 80 medium. The radiolabeled precursors and different concentrations of the inhibitors (0.5 to 10x MIC) were added simultaneously to the cultures, which were then allowed to grow for another 12-16 hr at 37ºC. M. tb cultures treated with different concentrations of control drugs with known mechanisms of action were analyzed alongside to assess the specificity of the inhibitor for any observed effects. ). Untreated and inhibitor-treated bacteria were collected by centrifugation, washed and their lipids and mycolyl-arabinogalactan-peptidoglycan (mAGP) complex extracted essentially as described (Mikušová et al., 1995) . In the case of DNA and RNA labeling, radiolabeled bacterial cultures were applied to glass fiber filters (Whatman GF/A 25mm) to get rid of the culture medium and bacterial pellets were then washed with cold PBS, quenched with 10% cold trifluoroacetic acid (TFA) for 15 min at 4ºC, and further washed with 10% TFA and 95% ethanol. Radioactivity incorporation was determined by scintillation counting. 35 S-protein-labeling mix incorporation was determined upon breaking washed cells in cold PBS using a bead beater, TCA precipitation of the lysates, and scintillation counting. All results were expressed as a percentage of incorporation in untreated controls.
developed in-house (Sartain et al., 2011) . Quantification of the compounds of interest was achieved by comparing their relative ratios in the samples.
Reagents and instrumentation -All reagents were purchased from Sigma Aldrich (Milwaukee, WI) and were used without any further purification. Silica gel flash columns were purchased form Biotage Inc. (Lake Forest, VA). Biotage Isolera FLASH column chromatography system was used to purify AU1235. Melting points were obtained on the OptiMelt MPA100 Automated Melting Point System. Chemical shifts (δ) are reported in parts per million relative to solvent peak and coupling constants (J) are reported in Hz. High resolution mass spectra were recorded on a Waters Xevo G2 QTOF LCMS using ESI. Purity of >98% for AU1235 was determined using RP-HPLC on a Shimadzu HPLC system. Gradient Conditions: solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in MeOH): 0-1.00 min 95% A, 1.00-6.00 min 0-95% B (linear gradient), 6.00-9.50 min 100% B, 9.50-9.75 min 0-95% A, 9.75-10.0 min 95% A, detection by UV at 254 nm and by ELSD.
Synthesis of 1-(2-adamantyl)-3-(2,3,4-trifluorophenyl)urea (AU1235) -2,3,4-Trifluorophenyl isocyanate(173 mg, 1.0 mmol), 2-adamantyl amine (181 mg, 1.2 mmol) and triethylamine (502 µL, 3.6 mmol) were dissolved in methylene chloride (10 ml) and stirred at room temperature overnight. The solvent was then removed under reduced pressure and the crude residue was purified by flash column chromatography using a hexane to ethyl acetate gradient. Pure compound (303 mg, 93%) was isolated as a white powder. 32.65, 37.34, 37.72, 54.16, 110.98, 111.16, 114.82, 126.13, 126.21, 140.77, 155.22 .
Analysis of AU1235 accumulation in M. tb cells by LC/MS -M. tb
H37Ra (wild-type strain and spontaneous mutant isolates # 5 and 25) were grown up to mid to late log phase in 7H9-OADC without Tween 80. Pellets from 2-5-ml cultures were resuspended in 1 ml of media containing 5 µM AU1235 and incubated at 37ºC for 4 hr with shaking. The cells were then extensively washed with PBS and broken in 1 ml ddH 2 O in a bead beater. Broken cells and beads were spun down at 12,000 x g for 10 min and kept as 'cell wall' fraction. The supernatant was removed and ~9 ml of ddH 2 O was added followed by ultracentrifugation for 1 hr at 4ºC at 100,000 x g to separate membrane and cytosolic fractions. Each of the 3 fractions was transferred into glass tubes and AU1235 was extracted with 3 ml of ethyl acetate (containing 0.17 µg of a related urea compound used as an internal standard) and water. The ethyl acetate layer was removed and dried down using a nitrogen bath and reconstituted in 100 µl of methanol. Two µl were analyzed by LC/MS as described below and the M+H ions at m/z 325 (AU1235) and m/z 345 (internal standard) were integrated. Using a standard curve, the amount of AU1235 per cell pellet was calculated. LC/MS analysis of adamantyl ureas: Samples were run on a Zorbax 2.1x50 mm SB-C18 1.8 µm (Agilent Technologies) column coupled to a high resolution Agilent 6220 TOF mass spectrometer. A 22 min solvent gradient, with a flow rate of 0.32 ml min -1 started with 90% solvent A (10 mM formic acid in water), 10% solvent B (10 mM formic acid in acetonitrile). After 2 min, the gradient was started and the solvent ramped to 10% solvent A in 10 min. This was held for 8 min followed by a gradient back to 90% solvent A in 2 min. 
II. Supplementary Results

Supplementary
Effect of AU1235 on arabinogalactan synthesis
[AU1235] µg ml (a) M. tb H37Ra cultured in 7H9-OADC broth was treated for 5 hr at 37°C with either no inhibitor (0) or with AU1235 (AU) at a concentration of 0.5 µg ml -1 (5 x MIC). Surface-exposed lipids were extracted from whole cells in water-saturated 1-butanol as described (Morita et al., 2005) , and the butanol-treated cells were then re-extracted overnight with chloroform/methanol (2:1, by vol.) to recover all remaining extractable lipids. The lipids from the butanol and chloroform/methanol fractions were resuspended in 400 µl of [chloroform: methanol] (2:1) and 5 µl of lipid sample were loaded per TLC lane. As a reference and control for inhibition, total lipids were also extracted from whole untreated and AU1235-treated cells. The TLC was developed in the solvent system [chloroform:methanol:water] (20:4:0.5, by vol.) and revealed and semi-quantified using a PhosphorImager. TMM, trehalose monomycolates; TDM, trehalose dimycolates. The relative distribution of TMM and TDM between the butanol (black bars) and chloroform/methanol fractions (red bars) is indicated on the adjacent graphs. A 3-fold decrease in the proportion of TMM found in the butanol fraction was observed in the treated cells (3.2% of total TMM) compared to the untreated ones (9.7% of total TMM). In comparison, the decrease in the proportion of TDM found in the butanol fraction of the treated cells was only 1.4-fold (1.1% in untreated cells compared to 0.8% in the treated ones). A cpm to cpm comparison is not possible here due to the fact that AU1235-treated whole bacilli (not pre-extracted with butanol) contained 3.7 times more TMM and 22 times less TDM than the untreated M. tb H37Ra bacilli.
T: AU1235-treated NT: non-treated (b-c) M. tb H37Ra cultured in 7H9-OADC broth was treated for 4.5 hr at 37°C with either no inhibitor (0) or with AU1235 (AU) at a concentration of 1 µg ml -1 (10 x MIC). [ 14 C]-acetate was added to the cultures at the same time as the inhibitor. Bacterial cultures were collected and subfractionated into membranes, cytosol and '20,000 x g fraction'. To this end, cells were broken in a bead beater. Broken cells and beads were spun down at 3,000 rpm for 10 min to remove unbroken and beads and the supernatant was further centrifuged at 20,000 x g for 40 min to pellet the '20,000 x g cell wall fraction' containing both cell wall and membrane components. Indeed, owing to the apparent tight association of membranes with cell wall components in mycobacteria (Morita et al., 2005) , the 20,000 x g 'cell wall' The mycolic acids esterified to arabinogalactan were prepared from delipidated cells as described (48). α, α' and epoxy refer to the three types of mycolic acids produced by M. smegmatis. The same volume of samples was loaded per lane. The TLC was developed thrice in the solvent system [n-hexanes:ethyl acetate] (95:5, by vol.) and revealed by autoradiography. The amount of radioactivity incorporated in the products of interest was semi-quantified using a PhosphoImager and the results (expressed as a % of the value measured in the untreated control) are presented as histograms under their corresponding autoradiograms. TMM, trehalose monomycolates; TDM, trehalose dimycolates; PE, phosphatidylethanolamine; CL, cardiolipin; MAMEs, mycolic acid methyl esters. The TMM transesterification assay described in reference 24 was used to measure the mycolyltransferase activity of the purified FbpA FbpB and FbpC proteins (30 µg) in the presence of cold TMM purified by preparative TLC from M. tb (15 µg), [U-14 C]trehalose (1.25 µCi ml -1 ; specific activity, 600 mCi mol -1 ; American Radiolabeled Chemicals Inc.) and 0 (CTL) or 0.5 µg ml -1 AU1235. Assays were conducted in a total volume of 200 µl and allowed to proceed for 60 min at 37ºC. The glycolipid products of the reaction were analyzed by TLC run in the same solvent system as described in Supplementary Fig. 3a . 
